Study of the Stability of Sandoz Rituximab Biosimilar Rixathon<sup>®</sup>/Riximyo<sup>®</sup> When Subjected for up to 21 Days to Ambient Storage.

Drugs R D · 2022 · PMC9433506 · PMID 35933639

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

At OOF condition II (30 ± 2 °C/65 ± 5% RH), Batch 1 and Batch 2 do not show a relevant trend; Batch 3 has a decreasing trend, which might be still due to bioassay result fluctuations (see the fluctuations Batch 1 shows at OOF II condition).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.